文献速递关节外科骨质疏松与代谢性骨病

全髋关节置换术结局:单中心18年经验:系统性红斑狼疮是不良结局的潜在危险因素吗?

Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes?
PubMed 文献 · J Arthroplasty · 2017-06-19

该回顾性队列研究纳入1995至2013年墨西哥城某三级中心58例接受全髋关节置换术的系统性红斑狼疮患者,并与类风湿关节炎和骨关节炎各58例对照比较。系统性红斑狼疮患者总体并发症更多,多变量分析显示系统性红斑狼疮是全髋关节置换术并发症的独立危险因素(HR 2.8),但远期并发症各组相似,长期结局良好。

要点

  • 系统性红斑狼疮患者全髋关节置换术后总体并发症发生率高于类风湿关节炎和骨关节炎对照组。
  • 多变量分析显示系统性红斑狼疮是全髋关节置换术并发症的独立危险因素(HR 2.8)。
  • 系统性红斑狼疮患者远期并发症与其他组相似,长期结局良好。

核心结论

  • 系统性红斑狼疮是全髋关节置换术后不良结局(主要为近期并发症)的独立危险因素,但长期结局良好,足以支持手术治疗以改善生活质量。

研究设计与样本

  • 1995至2013年在墨西哥城一家三级医疗中心开展的回顾性队列研究,纳入58例接受全髋关节置换术的系统性红斑狼疮患者,并与类风湿关节炎58例和骨关节炎58例按性别和手术日期匹配对照。

主要发现

  • 系统性红斑狼疮患者更年轻(P < .0001),住院时间更长(P = .001),需要更多输血(P = .004)。
  • 系统性红斑狼疮患者全髋关节置换术总体并发症发生率高于类风湿关节炎患者(36.2% vs 15.5%,P = .029)。
  • 系统性红斑狼疮患者全髋关节置换术总体并发症发生率高于骨关节炎患者(36.2% vs 5.1%,P < .0001)。
  • 多变量分析显示,全髋关节置换术并发症的危险因素为系统性红斑狼疮(风险比 2.8,95%置信区间 1.2-6.8;P = .018)和术后低血红蛋白(风险比 0.77,95%置信区间 0.73-0.83;P < .0001)。
  • 全髋关节置换术后远期并发症在各组间相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In patients with systemic lupus erythematosus (SLE), persistent joint activity and treatment with glucocorticoids are associated with musculoskeletal complications. About 30% of these patients become candidates for surgical treatment. The aim of this study was to evaluate postoperative outcomes after total hip arthroplasty (THA) in SLE patients. METHODS: We performed a retrospective cohort study at a tertiary care center in Mexico City between 1995 and 2013. All patients with SLE who underwent THA during that period were included (n = 58). They were compared with 2 control groups, one from another inflammatory arthropathy (rheumatoid arthritis, n = 58) and other noninflammatory (osteoarthritis, n = 58), matched by gender and date of surgery. The primary outcome was the frequency of postoperative complications during follow-up. RESULTS: We included 174 patients who underwent THA during the study period. Patients with SLE were younger (P < .0001), had a longer hospitalization stay (P = .001), and required more transfusions (P = .004). Global complications in THA in patients with SLE were more prevalent than rheumatoid arthritis (36.2% vs 15.5%, P = .029) and osteoarthritis (36.2% vs 5.1%, P < .0001) patients. After multivariate analysis, risk factors for THA complications were: SLE (hazard ratio 2.8, 95% confidence interval 1.2-6.8; P = .018) and low postoperative hemoglobin (hazard ratio 0.77, 95% confidence interval 0.73-0.83; P < .0001). Long-term complications after THA were similar among groups. CONCLUSION: This is the largest single-center study regarding clinical outcomes after THA in SLE patients. Our data suggest that SLE is an independent risk factor for adverse postoperative outcomes, mainly immediate complications, but the long-term outcome is good enough to offer surgical treatment that will improve quality of life.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Merayo-Chalico J, Gónzalez-Contreras M, Ortíz-Hernández R, et al. Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes? J Arthroplasty. 2017. PMID: 28709759. doi:10.1016/j.arth.2017.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。